Science & Technology Innovation Center, Hunan University of Chinese Medicine, Changsha, PR China.
School of Life Science and Technology, Central South University of Forestry and Technology, Changsha, PR China.
J Ethnopharmacol. 2024 Jan 10;318(Pt B):117010. doi: 10.1016/j.jep.2023.117010. Epub 2023 Aug 7.
Huzhang-Guizhi herb pair (HGHP), composed of Polygonum cuspidatum (Huzhang [HZ] in Chinese, the root of Polygonum cuspidatum Sieb. & Zucc.) and Ramulus Cinnamomi (Guizhi [GZ] in Chinese, the dried twig of Cinnamomum cassia Presl.), is a popular herb pair commonly used to treat arthritis and involved in many Chinese prescriptions. In order to reveal the influence of GZ on HZ on bioavailability, the pharmacokinetic behaviors and tissue distribution variations of the three analytes from HZ were detected between oral administration of HZ and HGHP extracts to rats.
Male Sprague-Dawley rats were randomly assigned to two groups for pharmacokinetics study and eight groups for tissues distribution research with the equivalent dose of 18 g crude HZ/kg. Assays for analytes from HZ (polydatin, resveratrol, emodin) were developed and validated using high performance liquid chromatography with ultraviolet detection (HPLC-UV).
Part pharmacokinetic parameters including area under the concentration-time curve (AUC), the maximum plasma concentration (C), biological half-life (t), mean residence time (MRT), time to peak concentration (T), clearance rate/bioavailability (CL/F) and volume of distribution/bioavailability (Vd/F) showed significant difference (P < 0.05) after oral administration of HGHP, as compared to those of HZ. The three analytes could be detected in heart, liver, spleen, lung, kidney and brain. Compared with the HZ group, AUC of polydatin in heart, liver and kidney increased significantly (p < 0.05) while that in spleen decreased significantly (p < 0.05); AUC of resveratrol in all detected tissues increased conspicuously (p < 0.05) in the HGHP group; AUC of emodin in heart, liver, spleen, lung, and kidney increased conspicuously (p < 0.05), and decreased obviously (p < 0.05) in brain in the HGHP group.
GZ could strongly influence the pharmacokinetic parameters and tissue distribution characteristics of polydatin, resveratrol and emodin in rats when administrated with HZ or HGHP extracts. It might provide a reference for further explanation of the compatibility mechanism and the clinical application of HGHP.
虎杖-桂枝药对(HGHP)由虎杖(HZ)和桂枝(GZ)组成,是一种常用的治疗关节炎的草药对,涉及许多中药方剂。为了揭示 GZ 对 HZ 生物利用度的影响,检测了大鼠口服 HZ 和 HGHP 提取物后,HZ 中三种分析物的药代动力学行为和组织分布变化。
雄性 Sprague-Dawley 大鼠随机分为两组进行药代动力学研究,八组进行组织分布研究,剂量为 18g 生 HZ/kg。采用高效液相色谱法(HPLC-UV)检测 HZ 中分析物(白藜芦醇、大黄素)的含量。
与 HZ 组相比,HGHP 组的部分药代动力学参数(AUC、Cmax、t1/2、MRT、Tmax、CL/F 和 Vd/F)差异有统计学意义(P<0.05)。三种分析物均可在心、肝、脾、肺、肾和脑中检测到。与 HZ 组相比,HGHP 组中白藜芦醇在心、肝、肾中的 AUC 显著增加(p<0.05),而在脾中的 AUC 显著降低(p<0.05);HGHP 组中各组织的大黄素 AUC 均显著增加(p<0.05);HGHP 组中大黄素在心、肝、脾、肺、肾中的 AUC 显著增加(p<0.05),在脑中的 AUC 显著降低(p<0.05)。
当大鼠同时服用 HZ 或 HGHP 提取物时,GZ 可强烈影响白藜芦醇、大黄素和大黄素在大鼠体内的药代动力学参数和组织分布特征。这可能为进一步解释 HGHP 的配伍机制和临床应用提供参考。